Syntekabio
Latest round
- Series C
Last raised
- Jul 2019
Total raised
- $33M
Investors
- 13
About Syntekabio
Based in South Korea, Syntekabio, Inc.Founded in 2009 and headquartered in Daejeon, South Korea, Syntekabio, Inc. focuses on AI-based solutions for drug development.2 billion in an IPO on December 17, 2019, and has completed a total of four deals.Syntekabio is a leader in AI-driven drug discovery, offering a range of innovative products and services aimed at streamlining the drug development process. Their core offerings include the DeepMatcher AI Drug Platform, which enables continuous and automated production of drug candidates through a factory-like model of drug discovery. This platform provides significant advantages in generating drug candidates for over 100 disease targets, facilitating the rapid validation of candidates for Investigational New Drug (IND) status. The company also specializes in tailored solutions such as the Sm-ARS for small molecule drugs, NEO-ARS for neoantigen prediction in cancer therapies, and Ab-ARS for antibody drug candidates.4. The company is likely focusing on upcoming products designed to enhance its existing platforms, and is targeting expansion into new geographic markets, although specific regions and timelines for this expansion have not been disclosed.
Who invested in Syntekabio
13 investors across 3 rounds
See all investors in Syntekabio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Syntekabio
Who invested in Syntekabio?
Syntekabio has 13 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Syntekabio raised?
Syntekabio has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Syntekabio last raise money?
Syntekabio's most recent round on record is a Series C, in Jul 2019.
What does Syntekabio do?
Based in South Korea, Syntekabio, Inc.
Where is Syntekabio headquartered?
Syntekabio is headquartered in Daejeon, South Korea.
Which VCs invest in companies like Syntekabio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Syntekabio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Syntekabio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.